How do you envision genomic scoring systems for pediatric cancers being applied in a real-world setting?

We see our impact in genomic scoring system being used to compare the impact of different and evolving tumor genomic sequencing platforms as the NGS assays (and soon cell free tumor (CT) DNA NGS platforms) are constantly being refined and used for clinical care decisions. Some platforms are more com...

I think scoring systems like these are promising, but they must be validated before being ready for application in the clinical setting. A scoring system can be helpful for clinicians, patients, and families, but only if it is based on verified, valid data, which is easier said than done. Many such ...